Skip to main content

Advertisement

Table 4 Results for overall and sub-group analysis according to type of study and treatment

From: Community based interventions for the prevention and control of Non-Helmintic NTD

Outcomes Estimates (95% CI)  
  Combined RCTs Pre-post studies Preventive Therapeutic
Chagas
Peri-domiciliary Infestation Rate 0.77 [0.53, 1.14] 0.94 [0.67, 1.32] 0.17 [0.06, 0.48] 0.77 [0.53, 1.14] No studies
8 datasets, 3 studies 4 datasets, 1 study 4 datasets, 2 studies 8 datasets, 3 studies
Domiciliary Infestation Rate 0.32 [0.19, 0.55] No studies 0.32 [0.19, 0.55] 0.32 [0.19, 0.55] No studies
4 datasets, 2 studies   4 datasets, 2 studies 4 datasets, 2 studies
Chagas Serology Rate (RR) 0.78 [0.61, 0.98] No studies 0.78 [0.61, 0.98] 0.78 [0.61, 0.98] No studies
4 datasets, 2 studies 4 datasets, 2 studies 4 datasets, 2 studies
Dengue
House Index 0.84 [0.81, 0.88] No studies 0.84 [0.81, 0.88] 0.84 [0.81, 0.88] No studies
9 datasets, 9 studies 9 datasets, 9 studies 9 datasets, 9 studies
Ovitrap Index 0.77 [0.64, 0.92] No studies 0.77 [0.64, 0.92] 0.77 [0.64, 0.92] No studies
5 datasets, 3 studies 5 datasets, 3 studies 5 datasets, 3 studies
Mean Bretreau Index (SMD) −0.04 [−0.28, 0.19] −0.04 [−0.28, 0.19] No studies −0.04 [−0.28, 0.19] No studies
5 datasets, 2 studies 5 datasets, 2 studies 5 datasets, 2 studies
Dengue Positive Serostatus 0.31 [0.18, 0.53] 0.33 [0.18, 0.60] 0.14 [0.01, 1.62] 0.31 [0.18, 0.53] No studies
4 datasets, 4 studies 2 datasets, 2 studies 2 datasets, 2 studies 4 datasets, 4 studies
Trachoma
Active Trachoma All Age Groups 0.24 [0.21, 0.26] 0.72 [0.59, 0.88] 0.15 [0.14, 0.17] 0.72 [0.59, 0.88] 0.15 [0.14, 0.17]
6 datasets, 3 studies 2 datasets, 1 study 4 datasets, 2 studies 2 datasets, 1 study 4 datasets, 2 studies
Active Trachoma in Children 0.67 [0.64, 0.69] 0.86 [0.83, 0.90] 0.38 [0.36, 0.40] 0.77 [0.74, 0.79] 0.32 [0.29, 0.35]
20 datasets, 14 studies 6 datasets, 4 studies 14 datasets, 9 studies 13 datasets, 8 studies 7 datasets, 6 studies
Chlamydia Trachomatic infection- All Age Groups 0.29 [0.27, 0.32] 0.28 [0.25, 0.31] 0.32 [0.27, 0.37] 0.28 [0.25, 0.31] 0.36 [0.29, 0.46]
10 datasets, 6 studies 5 datasets, 3 studies 5 datasets, 3 studies 7 datasets from 5 studies 3 datasets, 1 studies
Chlamydia Trachomatic infection in Children 0.21 [0.18, 0.24] 0.15 [0.13, 0.19] 0.42 [0.31, 0.55] 0.21 [0.18, 0.24] No studies
9 datasets, 7 studies 6 datasets, 4 studies 3 datasets, 3 studies 9 datasets, 7 studies
Leishmaniasis
Incidence Cutaneous Leishmaniasis 0.42 [0.36, 0.49] 0.40 [0.32, 0.51] 0.43 [0.35, 0.53] 0.42 [0.36, 0.49] No studies
9 datasets, 5 studies 5 datasets, 3 studies 4 datasets, 2 studies 9 datasets, 5 studies
Incidence of Visceral Leishmaniasis 0.93 [0.83, 1.04] 0.97 [0.84, 1.12] 0.87 [0.73, 1.04] 0.93 [0.83, 1.04] No studies
4 datasets, 4 studies 2 datasets, 2 studies 2 datasets, 2 studies 4 datasets, 4 studies
Cure Rate for Cutaneous Leishmaniasis (RR) 0.92 [0.88, 0.96] No studies 0.92 [0.88, 0.96] No studies 0.92 [0.88, 0.96]
2 datasets, 2 studies 2 datasets, 2 studies 2 datasets, 2 studies
Leprosy
Leprosy Incidence 0.32 [0.30, 0.34] 0.67 [0.49, 0.92] 0.31 [0.29, 0.33] 0.32 [0.30, 0.34] No studies
8 datasets, 5 studies 1 datasets, 1 studies 7 datasets, 4 studies 8 datasets, 5 studies
Leprosy detection rate 1.11 [1.02, 1.21] No studies 1.11 [1.02, 1.21] 1.11 [1.02, 1.21] No studies
  2 datasets, 2 studies   2 datasets, 2 studies 2 datasets, 2 studies  
  1. Estimates in bold represents statistical significance.